We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Technique Helps Sick Lungs Deliver Oxygen

By HospiMedica staff writers
Posted on 08 Sep 2006
A new technique has been developed in animal models for using the abdominal cavity to exchange gases, supplementing the function normally performed by the lungs.

Researchers at the University of Pennsylvania School of Medicine (Philadelphia, USA) developed the technique, which involves recirculating inert perfluorocarbons--a class of compounds developed during the Manhattan Project that have an extraordinary gas-dissolving capacity--through the abdomen to deliver oxygen. More...


The researchers tested the system in adult pigs that were put to sleep and ventilated with low concentrations of oxygen to simulate lung failure. Using this technique, they observed an increase in arterial oxygen saturation--preferably in the 90% range--from 73% to 89%. The idea was inspired by peritoneal dialysis, a similar technique already used for patients suffering from kidney failure, in which a catheter is placed into the abdominal cavity and the blood is cleansed by using the lining of the abdominal cavity to exchange toxins and electrolytes. The research findings were published in the August 2006 issue of Chest, the journal of the American College of Chest Physicians.

"This is an alternate, novel way to deliver oxygen to the body that does not attempt to wring more function out of an already injured lung, by using ventilator settings that can actually exacerbate the underlying lung injury. The only other alternates that can ‘rest' the lung involve variations of bypass machine technology, all of which require anticoagulation,” said Joseph Friedberg, M.D., associate professor of surgery and principal investigator of the study. "The ability to rest the lungs and provide supplemental oxygen with a technique that appears nontoxic and does not require anticoagulants could have huge implications some day for patients suffering from potentially reversible pulmonary failure from such diseases as anthrax, bird flu, severe acute respiratory syndrome [SARS], trauma, acute respiratory distress syndrome [ARDS], pulmonary embolism, pneumonia, and others. Sometimes patients have a condition in which they might have a chance to recover if they could survive the most severe phase of their disease.”

An underlying problem of ventilation is ventilator-induced lung injury (VILI), a vicious cycle where the high vent settings required to support a patient with lung failure actually exacerbate the underlying lung disease, requiring even more vent support. A technique like abdominal perfusion, if proven to be safe and effective, could be used to short-circuit this positive feedback loop and "rest” the lungs instead of having them go into a potentially fatal spiral.



Related Links:
University of Pennsylvania School of Medicine

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.